Interim Director Emily Farr
Customer Satisfaction Survey
Office of General Counsel
Office of Advice Counsel
Office of Communications and Governmental Affairs
The FDA is working closely with the CDC and state partners to investigate an outbreak of meningitis among patients who received epidural steroid injections. While the investigation into the exact source of the outbreak is still ongoing, a potentially contaminated product, a preservative-free methylprednisolone acetate (80mg/ml), an injectable steroid compounded and distributed by New England Compounding Center in Framingham, Massachusetts, is suspected to be the cause of the outbreak.
For more information concerning the meningitis outbreak, please visit the SCDHEC Public Health Notifications page: http://www.scdhec.gov/health/disease/han/notifications.htm
and the CDC website: http://www.cdc.gov/HAI/outbreaks/meningitis.html.